Founded in 2013
They are a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. They are leveraging new technology to create virtuous cycles of learning around datasets...
David Beyer
Investor
James Hardiman
Investor and Board Observer
Zavain Dar
Board Director
Spencer Schreier
Research Associate III
Kristen Rushton
Senior Vice President Business Operations
Marnie Binette, Cpp
Sr Payroll Manager
Haley Scott
Executive Assistant to the CEO
Michael Secora Phd
Chief Financial Officer
William Mcmain
Senior Software Engineer